Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 0.0
SYVC On Other Exchanges
As of 8:10 PM 11/23/15 All times are local (Market data is delayed by at least 15 minutes).

synovics pharmaceuticals inc (SYVC) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/16/14 - $0.0099
52 Week Low
11/23/15 - $0.0001
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

synovics pharmaceuticals inc (SYVC) Related Businessweek News

No Related Businessweek News Found

synovics pharmaceuticals inc (SYVC) Details

Synovics Pharmaceuticals, Inc., through its subsidiaries, develops, manufactures, and commercializes generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It also offers private label solid dosage Rx products, including Estratest, a product used by post-menopausal women. The company packages and distributes its private label, or store brand OTC products to chain drug stores, wholesalers, and distributors in the United States. It primarily has strategic alliance agreement with Maneesh Pharmaceuticals Pvt., Ltd. and Harcharan (Harry) Singh. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Ft. Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.

155 Employees
Last Reported Date: 06/12/09
Founded in 1983

synovics pharmaceuticals inc (SYVC) Top Compensated Officers

Interim Principal Executive Officer and Direc...
Total Annual Compensation: --
Chairman of InCon Technologies Inc., Chairman...
Total Annual Compensation: --
Director of Technical Operations
Total Annual Compensation: --
Vice President of Business Development of Kir...
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SYVC:US $0.00 USD 0.00

SYVC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SYVC.
View Industry Companies

Industry Analysis


Industry Average

Valuation SYVC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.0x
Price/Book NM Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SYNOVICS PHARMACEUTICALS INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at